Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 52 for “"Cardioversion"”.
-
Φαρμακευτική έναντι ηλεκτρικής ανάταξης σε ασθενείς με κολπική μαρμαρυγή στο τμήμα επειγόντων περιστατικών: συσχέτιση με βιοχημικούς δείκτες και πρόγνωση ασθενών
… (NT-proBNP) in predicting both the outcome of AF cardioversion and the risk of AF recurrence or persistence on the 8th (D8) and 30th (D30) day post-cardioversion. Methods: This prospective, observational study evaluated patients with recent-onset AF, managed by either pharmacological (PC) or …
-
Η αποτελεσματικότητα του συνδυασμού προπαφαινόνης και ιμπουτιλίδης στην ανάταξη της κολπικής μαρμαρυγής πρόσφατης έναρξης
… days) admitted for elective pharmacological cardioversion, were randomly assigned to either treatment with intravenous ibutilide (1 mg plus additional 1 mg, if required) (n =51) or oral propafenone (600 mg) plus intavenous ibutilide at the same dosage (n=49). Success rates were 41,1% (21 of …
-
ΑΝΑΤΑΞΗ ΤΗΣ ΧΡΟΝΙΑΣ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ ΜΕ ΕΝΔΟΚΑΡΔΙΑΚΗ ΑΠΙΝΙΔΩΣΗ. AΜΕΣΑ ΚΑΙ ΑΠΩΤΕΡΑ ΑΠΟΤΕΛΕΣΜΑΤΑ
… AND LONG-TERM RESULTS OF INTERNAL VS EXTERNAL CARDIOVERSION REGARDING THE CONVERSION OF CHRONIC ATRIAL FIBRILLATION AND MAINTENANCE OF SINUS RHYTHM. METHODS: FORTY PATIENTS (MEAN AGE 57 +- 8 YEARS) WITH CHRONIC ATRIAL FIBRILLATION (MEAN TIME OF DURATION 12 +- 20 MONTHS) WERE INCLUDED IN THE …
-
Συνδυασμός ρανολαζίνης - αμιωδαρόνης έναντι αμιωδαρόνης στο χρόνο ανάταξης της πρωτοεμφανισθείσας (new-onset) ή παροξυσμικής κολπικής μαρμαρυγής και εκτίμηση λειτουργικής συμπεριφοράς του αριστερού κόλπου
… rhythm, ventricular rate control, electrical cardioversion, or catheter ablation techniques in casesdrug-resistant episodes. Among medications used for the management of this arrhythmia, Amiodarone remains the first-line drug for conversion of recurrent AF paroxysms, however most commonly with …
-
A Study of Thrombogenesis in Atrial Fibrillation and Left Ventricular Dysfunction
… identified together with a reluctance to perform cardioversion or to commence anticoagulant therapy. This being despite the increasingly important roles for these two therapeutic manoeuvres in the current management of atrial fibrillation. One possible reason for the low rate of introducing …
-
Effect of AT1-antagonist (eprosartan) on the mechanical dysfunction ("atrial stunning") after DC shock of atrial strip of patients with and without atrial fibrillilation
… ablation), pharmacological, and spontaneous cardioversion of AF. This condition is responsible for an increased thrombo-embolic risk after cardioversion of atrial fibrillation. AT1-antagonists have been reported to attenuate atrial remodelling in AF. Could these theoretically influence …
-
Markers of Left Atrial Fibrosis in Atrial Fibrillation and Prediction of Successful Rhythm Control Intervention
… rhythm include catheter ablation and electrical cardioversion. Myocardial fibrosis is associated with recurrence and may be measurable using circulating biomarkers. Other methods include cardiac magnetic resonance (CMR) and electro-anatomical mapping. The aims were: 1) Compare biomarkers in AF …
-
Anticoagulant and antiarrhythmic agents for atrial fibrillation
… indices of AF organization as predictors of cardioversion with vernakalant. A considerable proportion of AF patients do not receive adequate stroke prevention therapy with oral anticoagulation, despite increased guideline adherence. Efforts to reduce under-treatment should particularly be …
-
Η σχέση των πρωτεϊνών θερμικής καταπληξίας HSP 70 με τη φλεγμονή σε ασθενείς με κολπική μαρμαρυγή
… was administered in all ROAF patients forcardioversion and rhythm control. Serum levels of HSP70, interleukin-2 (sIL-2) andinterleukin-4 (sIL-4) were measured before and 48 hours after the iv administrationof amiodarone and we investigated their correlation to cardioversion or reccurence …
-
Περιορισμός της βλάβης από επαναιμάτωση στο οξύ έμφραγμα του μυοκαρδίου με την αναστολή της μιτοχονδριακής αντλίας Νa+ / Ca2+
… 1.5±1.1 vs 3.5±1.9, p=0.014), b) easier cardioversion of ventricular tachyarrhythmias (defibrillations required for cardioversion of each ventricular fibrillation episode: 2.6±2.3 vs 6.2±2.1, p=0.006), and c) decreased maximal depression of the J point (0.75±0.27 mm vs 1.75±0.82 mm, …
-
Study of the Kalman filter for arrhythmia detection with intracardiac electrograms
… and ventricular tachycardia (VT) by low-energy cardioversion or antitachycardia pacing. The schemes for detecting cardiac arrhythmias often realize nonpathologic tachycardia as serious arrhythmias and deliver false shocks. In this study, an arrhythmia classification technique has been developed …
-
Emergency department treatment of clinically stable paroxysmal atrial fibrillation.
… and aggressive (pharmacologic and/or electrical cardioversion) treatment were analyzed. Results. 169 patients were analyzed, 32 treated conservatively and 137 aggressively. 83.9% of aggressively treated patients converted in the ED, 8.0% were admitted, and 52.3% stayed in sinus rhythm for four …
-
A Deep Learning Classifier for Detecting Atrial Fibrillation in Hospital Settings Applicable to Various Sensing Modalities
… from forty-six AF subjects scheduled for cardioversion who were enrolled in a clinical study that was approved by the Internal Review Committees to protect human subjects at the University of Rochester Medical Center (URMC, Rochester, NY), and the Rochester Institute of Technology (RIT, …
-
High Resolution Multi-parametric Diagnostics and Therapy of Atrial Fibrillation: Chasing Arrhythmia Vulnerabilities in the Spatial Domain
… well to such treatments.There are electrical cardioversion options but there is not a practical implanted deploymentof this strategy. Under the current bioelectric therapy paradigm there is a trade-off betweenefficacy and the pain and risk of myocardial damage, all of which are positively …
-
The Experiences of Women Who Live with an Implantable Cardioverter-Defibrillator (lCD)
… attempts to correct these arrhythmias by pacing, cardioversion, and defibrillation thereby providing lifesaving therapy to patients at risk for sudden cardiac death. Currently, 150,000 Americans receive ICDs each year. Although most lCD recipients are men, more women are now qualifying for …
-
Atrial Arrhythmogenic Substrates: The Role of Structure and Molecular Remodeling
… pro-arrhythmic side effects. Electrical cardioversion, on the other hand, is extremely effective in terminating these arrhythmias, but the high-energy shocks required for termination cause substantial pain to the patient. In this dissertation, we first investigate the underlying molecular …
-
Propagation Dynamics in Cardiac Tissue: From Alternans Formation to Defibrillation
… important marker of arrhythmia risk. Electrical cardioversion is the standard shock-based treatment used to restore normal rhythm clinically, but current devices rely on high-energy shocks, which can be painful and may cause tissue damage. To develop safer, low-energy alternatives, we need to …
-
Investigating relationships between thromboembolic risk and left atrial structure, function, and flow characteristics as assessed with advanced magnetic resonance techniques
… 37 patients with persistent AF before and after cardioversion and compared to those of patients in SR with a similar (moderate) stroke risk (N=35) and those obtained in low-risk controls in SR (N=23). Restoration of SR after cardioversion led to improvement in LV systolic function and in all LA …
Page 1 of 3